Cargando…
Multiple drugs: COVID-19, off label use and increased serum tacrolimus level following interaction: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379045/ http://dx.doi.org/10.1007/s40278-021-01102-4 |
Ejemplares similares
-
Multiple drugs: Increased tacrolimus blood trough levels due to interaction and off-label use: case report
Publicado: (2020) -
Hydroxychloroquine/lopinavir/ritonavir/tacrolimus interaction: Increased tacrolimus level secondary to pharmacokinetic drug interaction and off label use: case report
Publicado: (2021) -
Immunosuppressants/lopinavir/ritonavir interaction: Relapse or persisting shedding of COVID-2019 , increased level of tacrolimus and off-label use: case report
Publicado: (2021) -
Azithromycin/antiretrovirals/tacrolimus: Acute kidney injury following off-label use and interaction, and COVID-19 pneumonia: case report
Publicado: (2020) -
Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)